Advanced search
Publication Cover
International Journal of Nanomedicine Volume 13, 2018 - Issue
Submit an article Journal homepage
154
Views
52
CrossRef citations to date
0
Altmetric
Original Research

Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII

Lu Lu1 School of Pharmacy
,
Yue Ding2 Experiment Center for Teaching and Learning, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaCorrespondence[email protected]
,
Yong Zhang2 Experiment Center for Teaching and Learning, Shanghai University of Traditional Chinese Medicine, Shanghai, China
,
Rodney JY Ho3 Department of Pharmaceutics, University of Washington, Seattle, WA, USA
,
Yuan Zhao4 Center of Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai, China
,
Tong Zhang1 School of PharmacyCorrespondence[email protected]
&
Chunrong Guo2 Experiment Center for Teaching and Learning, Shanghai University of Traditional Chinese Medicine, Shanghai, China
 show all
Pages 1927-1944 | Published online: 29 Mar 2018

Citations (52)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Yuri Sugimoto, Tadaharu Suga, Mizuki Umino, Asako Yamayoshi, Hidefumi Mukai & Shigeru Kawakami. (2023) Investigation of enhanced intracellular delivery of nanomaterials modified with novel cell-penetrating zwitterionic peptide-lipid derivatives. Drug Delivery 30:1.
Read now
Chunjing Guo, Yanguo Su, Hui Wang, Min Cao, Ningning Diao, Zhongxin Liu, Daquan Chen & Ming Kong. (2022) A novel saponin liposomes based on the couplet medicines of Platycodon grandiflorum–Glycyrrhiza uralensis for targeting lung cancer. Drug Delivery 29:1, pages 2743-2750.
Read now
Lijuan Zhang, Shengan Zhang, Min Jiang, Lu Lu, Yue Ding, Ninghui Ma, Yuan Zhao, Sihan Xuchen & Nailian Zhang. (2021) Novel Timosaponin AIII-Based Multifunctional Liposomal Delivery System for Synergistic Therapy Against Hepatocellular Carcinoma Cancer. International Journal of Nanomedicine 16, pages 5531-5550.
Read now
Wei Yan, Sharon SY Leung & Kenneth KW To. (2020) Updates on The Use of Liposomes for Active Tumor Targeting in Cancer Therapy. Nanomedicine 15:3, pages 303-318.
Read now
Mesha Saeed, Sara Zalba, Ann L B Seynhaeve, Reno Debets & Timo L M ten Hagen. (2019) Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response. International Journal of Nanomedicine 14, pages 2069-2089.
Read now
Yating Sun, Yarong Zhao, Shanshan Teng, Fei Hao, Huan Zhang, Fanchao Meng, Xiuting Zhao, Xiaolong Zheng, Ye Bi, Yicheng Yao, Robert J Lee & Lesheng Teng. (2019) Folic acid receptor-targeted human serum albumin nanoparticle formulation of cabazitaxel for tumor therapy. International Journal of Nanomedicine 14, pages 135-148.
Read now
Marwa Mohamed, Amr S. Abu Lila, Taro Shimizu, Eman Alaaeldin, Amal Hussein, Hatem A. Sarhan, Janos Szebeni & Tatsuhiro Ishida. (2019) PEGylated liposomes: immunological responses. Science and Technology of Advanced Materials 20:1, pages 710-724.
Read now

Articles from other publishers (45)

Yong-Bo Zhang, Jun-Fang Wang, Mei-Xia Wang, Jing Peng, Xiang-De Kong & Jie Tian. (2024) Nano-based drug delivery systems for active ingredients from traditional Chinese medicine: Harnessing the power of nanotechnology. Frontiers in Pharmacology 15.
Crossref
Fengge Wang, Lu Liang, Ma Yu, Wenjie Wang, Iftikhar Hussain Badar, Yongping Bao, Kai Zhu, Yanlin Li, Saba Shafi, Dangdang Li, Yongchao Diao, Thomas Efferth, Zheyong Xue & Xin Hua. (2024) Advances in antitumor activity and mechanism of natural steroidal saponins: A review of advances, challenges, and future prospects. Phytomedicine 128, pages 155432.
Crossref
Eskandar Moghimipour & Somayeh Handali. (2024) Functionalized liposomes as a potential drug delivery systems for colon cancer treatment: A systematic review. International Journal of Biological Macromolecules 269, pages 132023.
Crossref
Ana Marques, Paulo Costa, Sérgia Velho & Maria Amaral. (2024) Analytical Techniques for Characterizing Tumor-Targeted Antibody-Functionalized Nanoparticles. Life 14:4, pages 489.
Crossref
Sebnem Ercelen, Bunyamin Bulkurcuoglu, Mustafa Oksuz, Ayse Nalbantsoy & Nazli Boke Sarikahya. (2024) Development and Characterization of Plant‐derived Aristatoside C and Davisianoside B Saponin‐loaded Phytosomes with Suppressed Hemolytic Activity. ChemistryOpen.
Crossref
Cheng-Zhe Gao, Hao-Ran Jia, Tian-Yu Wang, Xiao-Yu Zhu, Xiaofeng Han & Fu-Gen Wu. (2024) A dual drug-loaded tumor vasculature-targeting liposome for tumor vasculature disruption and hypoxia-enhanced chemotherapy. Chinese Chemical Letters, pages 109840.
Crossref
T. V. Bobik, M. A. Simonova, N. U. Rushkevich, N. N. Kostin, G. A. Skryabin, V. D. Knorre, A. A. Schulga, E. V. Konovalova, G. M. Proshkina, A. G. Gabibov & S. M. Deev. (2024) Immunoliposomes As a Promising Antiviral Agent against SARS-CoV-2. Doklady Biochemistry and Biophysics 514:1, pages 6-10.
Crossref
Intan Shazleen Ibrahim, Melbha Starlin Chellathurai, Syed Mahmood, Amirul Hakim Azmi, Norsyifa Harun, Mohd Ulul Ilmie Ahmad Nazri, Mohd Muzamir Mahat & Zarif Mohamed Sofian. (2024) Engineered liposomes mediated approach for targeted colorectal cancer drug Delivery: A review. International Journal of Pharmaceutics 651, pages 123735.
Crossref
Hanyun Tu, Xiaofeng Zhou, Haixia Zhou, Zepeng Luo, Yu Yan, Zhongping Luo & Qi Qi. (2024) Anti-tumor effect and mechanisms of Timosaponin AIII across diverse cancer progression. Biochemical Pharmacology, pages 116080.
Crossref
Yuxiang Wang, Wenzhen Wang, Hailu Yao, Jingjing Wang, Fenghe Yang, Yu Zhang, Guanhua Du & Guang Han. (2024) Glycyrrhizic Acid-Based Liposome for Tumor-Targeted Delivery of Cantharidin. ACS Applied Nano Materials 7:1, pages 1030-1044.
Crossref
Farzaneh Jabbari, Babak Akbari & Lobat Tayebi. 2024. Functionalized Nanomaterials for Cancer Research. Functionalized Nanomaterials for Cancer Research 181 195 .
Rajaganapathy Kaliyaperumal, Srinivasan Ranganathan, Masilamani Krishnamoorthy, Vasanth Kumar Mohan, Senthilnathan Balaraman, Gowri Rajapandian, Ramalingam Sathiyasundar & Saravanan Ravindran. (2023) Current Strategy of Monoclonal Antibody: Development, Cloning, Formulation and Drug Delivery. Recent Advances in Drug Delivery and Formulation 17:4, pages 264-285.
Crossref
Haohao Wang, Di Wu, Pan Wang, Chunyu Gao, Hongbo Teng, Dong Liu, Yan Zhao & Rui Du. (2023) Albumin nanoparticles and their folate modified counterparts for delivery of a lupine derivative to hepatocellular carcinoma. Biomedicine & Pharmacotherapy 167, pages 115485.
Crossref
Shishu Kant Suman, Archana Mukherjee & Rohit Kumar Sharma. (2023) A liposomal radionanoformulation for targeted drug delivery and real time monitoring by radionuclide imaging for HER2 overexpressing cancers. Drug Development Research 84:7, pages 1553-1563.
Crossref
Zhaowen Liu, Yifan Cao, Xiaohua Guo & Zhixi Chen. (2023) The Potential Role of Timosaponin-AIII in Cancer Prevention and Treatment. Molecules 28:14, pages 5500.
Crossref
Seyithan Kansız & Yaşar Murat Elçin. (2023) Advanced liposome and polymersome-based drug delivery systems: Considerations for physicochemical properties, targeting strategies and stimuli-sensitive approaches. Advances in Colloid and Interface Science 317, pages 102930.
Crossref
Xiaochen Chen, Hongying Yang, Changzhu Li, Wei Hu, Haiying Cui & Lin Lin. (2023) Enhancing the targeting performance and prolonging the antibacterial effects of clove essential oil liposomes to Campylobacter jejuni by antibody modification. Food Research International 167, pages 112736.
Crossref
Amir Hossein Mohammadi, Zeinab Ghazvinian, Fatemeh Bagheri, Masako Harada & Kaveh Baghaei. (2023) Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery. BioDrugs 37:3, pages 353-374.
Crossref
Behnaz Lahooti, Racheal G. Akwii, Dhavalkumar Patel, Siavash ShahbaziNia, Margarita Lamprou, Mahboubeh Madadi, Thomas J. Abbruscato, Aristotelis Astrinidis, Ulrich Bickel, Abraham Al-Ahmad, Nadezhda A. German, George Mattheolabakis & Constantinos M. Mikelis. (2023) Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles. Journal of Pharmacology and Experimental Therapeutics 385:1, pages 35-49.
Crossref
Kenan Aloss & Peter Hamar. (2023) Recent Preclinical and Clinical Progress in Liposomal Doxorubicin. Pharmaceutics 15:3, pages 893.
Crossref
Fatma Betül Arslan, Kıvılcım Öztürk, Ece Tavukçuoğlu, Süleyman Can Öztürk, Güneş Esendağlı & Sema Çalış. (2023) A novel combination for the treatment of small cell lung cancer: Active targeted irinotecan and stattic co-loaded PLGA nanoparticles. International Journal of Pharmaceutics 632, pages 122573.
Crossref
Ana Camila Marques, Paulo C. Costa, Sérgia Velho & Maria Helena Amaral. (2023) Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy. Pharmaceutics 15:1, pages 216.
Crossref
Adam Markowski, Magdalena Zaremba-Czogalla, Anna Jaromin, Ewa Olczak, Adrianna Zygmunt, Haniyeh Etezadi, Ben J. Boyd & Jerzy Gubernator. (2023) Novel Liposomal Formulation of Baicalein for the Treatment of Pancreatic Ductal Adenocarcinoma: Design, Characterization, and Evaluation. Pharmaceutics 15:1, pages 179.
Crossref
Ju Hyun LeeDana V. ChapmanW. Mark Saltzman. (2023) Nanoparticle Targeting with Antibodies in the Central Nervous System. BME Frontiers 4.
Crossref
Ipshita Menon, Maryam Zaroudi, Yuanzhe Zhang, Elizabeth Aisenbrey & Liwei Hui. (2022) Fabrication of active targeting lipid nanoparticles: Challenges and perspectives. Materials Today Advances 16, pages 100299.
Crossref
Arash Ramedani, Omid Sabzevari & Abdolreza Simchi. (2022) Hybrid ultrasound-activated nanoparticles based on graphene quantum dots for cancer treatment. International Journal of Pharmaceutics 629, pages 122373.
Crossref
Victor Araujo Correa, Amanda Izeli Portilho & Elizabeth De Gaspari. (2022) Vaccines, adjuvants and key factors for mucosal immune response. Immunology 167:2, pages 124-138.
Crossref
Lixia Chen, Jinshuai Lan, Zhe Li, Ruifeng Zeng, Yu Wang, Lu Zhen, Haojieyin Jin, Yue Ding & Tong Zhang. (2022) A Novel Diosgenin-Based Liposome Delivery System Combined with Doxorubicin for Liver Cancer Therapy. Pharmaceutics 14:8, pages 1685.
Crossref
Shuaikai Ren, Mengjie Wang, Chunxin Wang, Yan Wang, Changjiao Sun, Zhanghua Zeng, Haixin Cui & Xiang Zhao. (2021) Application of Non-Viral Vectors in Drug Delivery and Gene Therapy. Polymers 13:19, pages 3307.
Crossref
Hichem Moulahoum, Faezeh Ghorbanizamani, Figen Zihnioglu & Suna Timur. (2021) Surface Biomodification of Liposomes and Polymersomes for Efficient Targeted Drug Delivery. Bioconjugate Chemistry 32:8, pages 1491-1502.
Crossref
Yuyao Liao, Zhixun Li, Qing Zhou, Mengke Sheng, Qingsong Qu, Yanshuang Shi, Jiaqi Yang, Lijing Lv, Xingxing Dai & Xinyuan Shi. (2021) Saponin surfactants used in drug delivery systems: A new application for natural medicine components. International Journal of Pharmaceutics 603, pages 120709.
Crossref
Mohammad Houshmand, Francesca Garello, Rachele Stefania, Valentina Gaidano, Alessandro Cignetti, Michela Spinelli, Carmen Fava, Mahin Nikougoftar Zarif, Sara Galimberti, Ester Pungolino, Mario Annunziata, Luigia Luciano, Giorgina Specchia, Monica Bocchia, Gianni Binotto, Massimiliano Bonifacio, Bruno Martino, Patrizia Pregno, Fabio Stagno, Alessandra Iurlo, Sabina Russo, Silvio Aime, Paola Circosta & Giuseppe Saglio. (2021) Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome. Cancers 13:6, pages 1311.
Crossref
Reza Mahmoudi, Seyedeh Ashraf Mirahmadi-Babaheidri, Hamdollah Delaviz, Mohamad Hassan Fouani, Mohsen Alipour, Mehrzad Jafari Barmak, Gunna Christiansen & Hassan Bardania. (2020) RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells. Journal of Biomaterials Applications 35:7, pages 743-753.
Crossref
Liang Zhang. 2021. Liposome-Based Drug Delivery Systems. Liposome-Based Drug Delivery Systems 443 458 .
Yanan Li, Hailin Cong, Song Wang, Bing Yu & Youqing Shen. (2020) Liposomes modified with bio-substances for cancer treatment. Biomaterials Science 8:23, pages 6442-6468.
Crossref
Marwa Mohamed El Sayed, Haruka Takata, Taro Shimizu, Yoshino Kawaguchi, Amr S. Abu Lila, Nehal E. Elsadek, Eman Alaaeldin, Yu Ishima, Hidenori Ando, Amal Kamal, Hatem A. Sarhan & Tatsuhiro Ishida. (2020) Hepatosplenic phagocytic cells indirectly contribute to anti-PEG IgM production in the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes: Appearance of an unexplained mechanism in the ABC phenomenon. Journal of Controlled Release 323, pages 102-109.
Crossref
Yan Lin, Wai-Rong Zhao, Wen-Ting Shi, Jing Zhang, Kai-Yu Zhang, Qian Ding, Xin-Lin Chen, Jing-Yi Tang & Zhong-Yan Zhou. (2020) Pharmacological Activity, Pharmacokinetics, and Toxicity of Timosaponin AIII, a Natural Product Isolated From Anemarrhena asphodeloides Bunge: A Review. Frontiers in Pharmacology 11.
Crossref
A.C. Marques, P.J. Costa, S. Velho & M.H. Amaral. (2020) Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies. Journal of Controlled Release 320, pages 180-200.
Crossref
Jing Zhang, Xiang Li & Leaf Huang. (2020) Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment. Advanced Drug Delivery Reviews 154-155, pages 245-273.
Crossref
Han Young Kim, Mikyung Kang, Yeon Woong Choo, Seok-hyeong Go, Sung Pil Kwon, Seuk Young Song, Hee Su Sohn, Jihye Hong & Byung-Soo Kim. (2019) Immunomodulatory Lipocomplex Functionalized with Photosensitizer-Embedded Cancer Cell Membrane Inhibits Tumor Growth and Metastasis. Nano Letters 19:8, pages 5185-5193.
Crossref
Xiao-Yu Song, Feng-Ying Han, Jing-Jie Chen, Wei Wang, Yan Zhang, Guo-Dong Yao & Shao-Jiang Song. (2019) Timosaponin AIII, a steroidal saponin, exhibits anti-tumor effect on taxol-resistant cells in vitro and in vivo. Steroids 146, pages 57-64.
Crossref
Mohammad Rezaul Islam Shishir, Naymul Karim, Vemana Gowd, Xiaodong Zheng & Wei Chen. (2019) Liposomal delivery of natural product: A promising approach in health research. Trends in Food Science & Technology 85, pages 177-200.
Crossref
Liang Zhang. 2019. Liposome-Based Drug Delivery Systems. Liposome-Based Drug Delivery Systems 1 16 .
Darsheen J. Kotak, Pooja A. Todke, Prajakta Dandekar & Padma V. Devarajan. 2019. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis 383 406 .
Komal Parmar & Jayvadan K. Patel. 2019. Surface Modification of Nanoparticles for Targeted Drug Delivery. Surface Modification of Nanoparticles for Targeted Drug Delivery 221 236 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.